FDA Inspection 867653 — Vitalant

Vitalant — FEI 2973165

The FDA completed an inspection of Vitalant on Feb 25, 2014 in San Francisco, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 25, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Francisco, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
922521 CFR 606.171Biological product deviation report